Mendelspod Podcast
Christian Henry of PacBio on Long Reads at Scale, Next Moves
Feb 13, 2024
Exploring the impact of long reads at scale in sequencing technology. Discussing the decision between long and short reads. Plans for future instruments and insights into competing technologies.
05:41
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- PacBio's Revio technology revolutionized genomics by offering cost-effective long reads at scale, making sequencing thousands of genomes feasible below $1,000 each.
- PacBio's introduction of two major sequencing platforms in 2023 reshaped the genomic research landscape, highlighting the company's technological advancements and transformative impact.
Deep dives
Revio Revolutionizes Long Reads
The introduction of Revio by PacBio has transformed the genomics landscape by offering high throughput long reads at an affordable cost. With Revio, sequencing at scale has become achievable, enabling the processing of thousands of genomes efficiently and economically, costing well below $1,000 per genome. This advancement has shifted the industry focus from short read to long read genomes, with PacBio witnessing a significant increase in system shipments and the creation of petabytes of long read sequences.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
